BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30397609)

  • 41. Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine.
    Hasan A; Jain AG; Naim H; Munaf A; Everett G
    Cureus; 2018 Aug; 10(8):e3088. PubMed ID: 30324044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemolytic uremic syndrome associated with Clostridium difficile infection.
    Alvarado AS; Brodsky SV; Nadasdy T; Singh N
    Clin Nephrol; 2014 Apr; 81(4):302-6. PubMed ID: 23320969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A kidney biopsy is clearly mandatory to confirm the indication of plasma exchanges in adult haemolytic uraemic syndrome.
    Pourrat O; Touchard G; Robert R; Badia P; Bauwens M; Hauet T; Patte D
    Ann Med Interne (Paris); 1994; 145(5):369-72. PubMed ID: 7985952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombotic microangiopathy: new insights.
    Benz K; Amann K
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):242-7. PubMed ID: 20186056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
    Furmańczyk A; Komuda-Leszek E; Durlik M
    Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Haemolytic uraemic syndrome in children--a systematic review].
    Bayat A; Kamperis K; Rittig S
    Ugeskr Laeger; 2012 May; 174(19):1302-7. PubMed ID: 22564687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced thrombotic microangiopathy: incidence, prevention and management.
    Pisoni R; Ruggenenti P; Remuzzi G
    Drug Saf; 2001; 24(7):491-501. PubMed ID: 11444722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
    Walsh PR; Johnson S
    Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemolytic uraemic syndrome: a review.
    McLigeyo SO
    East Afr Med J; 1999 Mar; 76(3):148-53. PubMed ID: 10442115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer.
    Hausberg M; Felten H; Pfeffer S
    Case Rep Oncol; 2019; 12(1):1-6. PubMed ID: 30792638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report.
    Bally S; Fourcade J; Frémeaux-Bacchi V
    BMC Nephrol; 2019 May; 20(1):157. PubMed ID: 31064333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity.
    Chugh S; Kichloo A; Jafri F; Yusvirazi L; Lerner R
    J Investig Med High Impact Case Rep; 2017; 5(3):2324709617732797. PubMed ID: 28975130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.
    Morton JM; George JN
    J Oncol Pract; 2016 Jun; 12(6):523-30. PubMed ID: 27288467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A; Ardissino G; Angelini P; Giancaspro V; La Raia E; Nisi M; Proscia A; Tarantino G; Vitale O; D'elia F
    G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.